Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases

By Furuse Motomasa   Kawabata Shinji   Kuroiwa Toshihiko   Miyatake Shin-Ichi  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 471-475

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets

By Ramondetta L.M.   Burke T.W.   Jhingran A.   Schmandt R.   Bevers M.W.   Wolf J.K.   Levenback C.F.   Broaddus R.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 529-536

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Look K.Y.   Blessing J.A.   Levenback C.   Kohler M.   Chafe W.   Roman L.D.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 334-338

Elsevier

Access to resources Recommend Favorite

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma

By Phuphanich Surasak   Supko Jeffrey   Carson Kathryn   Grossman Stuart   Burt Nabors L.   Mikkelsen Tom   Lesser Glenn   Rosenfeld Steve   Desideri Serena   Olson Jeffrey  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite

Salvage chemotherapy With CPT-11 for recurrent meningioma

By Chamberlain Marc   Tsao-Wei Denice   Groshen Susan  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite